Identification of Common Prognostic Gene Expression Signatures with Biological Meanings from Microarray Gene Expression Datasets

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Yao, Jun ^a   Zhao, Qi ^c   Yuan, Ying ^a   Zhang, Li ^a   Liu, Xiaoming ^b   Yung, W K Alfred ^a   Weinstein, John N ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREAST CANCER; CANCER SURVIVAL; CELL PROLIFERATION; CHROMOSOME 10; GENE EXPRESSION; GENETIC ALGORITHM; GLIOBLASTOMA; HUMAN; LUNG ADENOCARCINOMA; MICROARRAY ANALYSIS; NOISE; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; PTEN GENE; SEX CHROMOSOME; TUMOR SUPPRESSOR GENE;

ADENOCARCINOMA; ALGORITHMS; BREAST NEOPLASMS; CLUSTER ANALYSIS; FEMALE; GENE EXPRESSION PROFILING; GLIOBLASTOMA; HUMANS; KAPLAN-MEIER ESTIMATE; LUNG NEOPLASMS; MALE; MODELS, BIOLOGICAL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; SEX FACTORS; TRANSCRIPTOME; TUMOR MARKERS, BIOLOGICAL;

EID: 84866652985     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0045894     Document Type: Article

References (25)

1. van 't Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AA, et al. (2002) Gene expression profiling predicts clinical outcome of breast cancer. Nature 415(6871): 530-536.
2. van de Vijver MJ, He YD, van't Veer LJ, Dai H, Hart AA, et al. (2002) A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 347(25): 1999-2009.
3. Miller LD, Smeds J, George J, Vega VB, Vergara L, et al. (2005) An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival. Proc Natl Acad Sci U S A 102(38): 13550-13555.
4. Pawitan Y, Bjohle J, Amler L, Borg AL, Egyhazi S, et al. (2005) Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts. Breast Cancer Res 7(6): R953-964.
5. Wang Y, Klijn JG, Zhang Y, Sieuwerts AM, Look MP, et al. (2005) Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet 365(9460): 671-679.
6. Sotiriou C, Wirapati P, Loi S, Harris A, Fox S, et al. (2006) Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis. J Natl Cancer Inst 98(4): 262-272.
7. Schmidt M, Bohm D, von Torne C, Steiner E, Puhl A, et al. (2008) The humoral immune system has a key prognostic impact in node-negative breast cancer. Cancer Res 68(13): 5405-5413.
8. Paik S, Shak S, Tang G, Kim C, Baker J, et al. (2004) A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med 351(27): 2817-2826.
9. Ein-Dor L, Kela I, Getz G, Givol D, Domany E, (2005) Outcome signature genes in breast cancer: is there a unique set? Bioinformatics 21(2): 171-178.
10. Fan C, Oh DS, Wessels L, Weigelt B, Nuyten DS, et al. (2006) Concordance among gene-expression-based predictors for breast cancer. N Engl J Med 355(6): 560-569.
11. Koscielny S, (2010) Why most gene expression signatures of tumors have not been useful in the clinic. Sci Transl Med 2(14): 14ps12.
12. Michiels S, Koscielny S, Hill C, (2005) Prediction of cancer outcome with microarrays: a multiple random validation strategy. Lancet 365(9458): 488-492.
13. Subramanian A, Tamayo P, Mootha VK, Mukerjee S, Ebert BL, et al. (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA. 102(43): 15545-50.
14. Shedden K, Taylor JM, Enkemann SA, Tsao MS, Yeatman TJ, et al. (2008) Gene expression-based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study. Nat Med 14(8): 822-827.
15. Eisen A, Weber BL, (1998) Recent advances in breast cancer biology. Curr Opin Oncol 10(6): 486-491.
16. Badve S, Nakshatri H, (2009) Oestrogen-receptor-positive breast cancer: towards bridging histopathological and molecular classifications. J Clin Pathol 62(1): 6-12.
17. Cicatiello L, Mutarelli M, Grober OM, Paris O, Ferraro L, et al. (2011) Estrogen receptor alpha controls a gene network in luminal-like breast cancer cells comprising multiple transcription factors and microRNAs. Am J Pathol 176(5): 2113-2130.
18. Thorner AR, Parker JS, Hoadley KA, Perou CM, (2011) Potential tumor suppressor role for the c-Myb oncogene in luminal breast cancer. PLoS One 5(10): e13073.
19. Kreike B, van Kouwenhove M, Horlings H, Weigelt B, Peterse H, et al. (2007) Gene expression profiling and histopathological characterization of triple-negative/basal-like breast carcinomas. Breast Cancer Res 9(5): R65.
20. Rody A, Karn T, Liedtke C, Pusztai L, Ruckhaeberle E, et al. (2011) A clinically relevant gene signature in triple negative and basal-like breast cancer. Breast Cancer Res 13(5): R97.
21. TCGA network, (2008) Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455(7216): 1061-1068.
22. Novello S, Vavala T, (2008) Lung cancer and women. Future Oncol 4(5): 705-716.
23. Paggi MG, Vona R, Abbruzzese C, Malorni W, (2010) Gender-related disparities in non-small cell lung cancer. Cancer Lett 298(1): 1-8.
24. Robinson BM, Kennedy C, McLean J, McCaughan BC, (2011) Node-Negative Non-small Cell Lung Cancer: Pathological Staging and Survival in 1765 Consecutive Cases. J Thorac Oncol 6(10): 1691-1696.
25. Haibe-Kains B, Desmedt C, Piette F, Buyse M, Cardoso F, et al. (2008) Comparision of prognostic gene expression signatures for breast cancer. BMC Genomics 9: 394.